Bill Text: TX HB2643 | 2023-2024 | 88th Legislature | Introduced
Bill Title: Relating to the disclosure of certain medical information by electronic means.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2023-03-13 - Referred to Public Health [HB2643 Detail]
Download: Texas-2023-HB2643-Introduced.html
| By: Price | H.B. No. 2643 | |
|
|
||
|
|
||
| relating to the disclosure of certain medical information by | ||
| electronic means. | ||
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
| SECTION 1. Section 159.006, Occupations Code, is amended by | ||
| amending Subsection (d) to read as follows: | ||
| (d) A physician shall provide the information requested | ||
| under this section: | ||
| (1) not later than the 15th business day after the date | ||
| of receipt of the written consent for release under Subsection (a) | ||
| or the written request under Subsection (c); and | ||
| (2) in accordance with Section 159.0065(b), if | ||
| applicable. | ||
| SECTION 2. Chapter 159, Occupations Code, is amended by | ||
| adding Section 159.0065 to read as follows: | ||
| Sec. 159.0065. SENSITIVE TEST RESULTS FURNISHED BY | ||
| ELECTRONIC MEANS. (a) In this section: | ||
| (1) “Electronic means” means a posting on a secure | ||
| electronic network or Internet website, including a secure online | ||
| patient portal or health software application, that: | ||
| (A) is accessible by an electronic device, | ||
| including a computer, mobile device, or tablet; and | ||
| (B) at which the patient or patient | ||
| representative has consented to receive the patient’s billing or | ||
| medical records. | ||
| (2) “Patient representative” means a person listed in | ||
| Subdivisions (1) through (4) of Section 159.005. | ||
| (3) “Sensitive test results” means: | ||
| (A) pathology reports or radiology reports that | ||
| have a reasonable likelihood of showing a finding of malignancy; or | ||
| (B) test results that could reveal genetic | ||
| markers. | ||
| (b) Sensitive test results may not be disclosed to a patient | ||
| or patient representative by electronic means until at least three | ||
| days after the sensitive test results are finalized. | ||
| (c) A person is not subject to civil, criminal, or | ||
| administrative liability or professional disciplinary action for | ||
| failure to comply with Section 159.006(d)(2) or Subsection (b) of | ||
| this section. | ||
| SECTION 3. This Act takes effect September 1, 2023. | ||
